Relevance of depression for anticoagulation management in a routine medical care setting: Results from the ThrombEVAL study program

Journal of Thrombosis and Haemostasis

Volumn 12, Issue 12, 2014, Pages 2024-2033

  Michal, M ^a,b   Prochaska, J H ^a   Ullmann, A ^a   Keller, K ^a   Gobel, S ^a   Coldewey, M ^a   Munzel T ^a,b   Wiltink, J ^a   Beutel, M E ^a   Wild, P S ^a,b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Ambulatory care; Anticoagulants; Depression; Medication adherence; Patient satisfaction; Phenprocoumon

Indexed keywords

ANTICOAGULANT AGENT; PHENPROCOUMON; WARFARIN;

AGED; ALOPECIA; AMBULATORY CARE; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BARTHEL INDEX; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEEP VEIN THROMBOSIS; DEPRESSION; DIARRHEA; DRUG HYPERSENSITIVITY; EMPATHY; FEMALE; HEALTH LITERACY; HEART ATRIUM FIBRILLATION; HEPATITIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL HISTORY; MEDICATION COMPLIANCE; MENTAL HEALTH; NAUSEA; PATIENT HEALTH QUESTIONNAIRE 2; PATIENT SATISFACTION; PRURITUS; RASH; SELF REPORT; SKIN NECROSIS; COHORT ANALYSIS; COMPLICATION; CROSS-SECTIONAL STUDY; MIDDLE AGED; MULTIVARIATE ANALYSIS; ORAL DRUG ADMINISTRATION; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; AMBULATORY CARE; ANTICOAGULANTS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SATISFACTION; PHENPROCOUMON; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84916613391     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12743     Document Type: Article

References (45)

1. Prochaska JH, Coldewey M, Göbel S, Keller K, Hendelmeier M, Konstantinides S, Münzel T, Wild PS, Group fttS. Evaluation of oral anticoagulation therapy: rationale and design of the thrombEVAL study programme. Eur J Prev Cardiol 2014. doi: 10.1177/2047487314527852.
2. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-9.
3. Cruess DG, Localio AR, Platt AB, Brensinger CM, Christie JD, Gross R, Parker CS, Price M, Metlay JP, Cohen A, Newcomb CW, Strom BL, Kimmel SE. Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinics. Int J Behav Med. 2010; 17: 33-42.
4. Platt AB, Localio AR, Brensinger CM, Cruess DG, Christie JD, Gross R, Parker CS, Price M, Metlay JP, Cohen A. Risk factors for nonadherence to warfarin: results from the IN RANGE study. Pharmacoepidemiol Drug Saf 2008; 17: 853-60.
5. Caraco Y, Blotnick S, Muszkat M. CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study. Clin Pharmacol Ther 2008; 83: 460-70.
6. Higashi MK, Veenstra DL, Kondo LM, Wittkowsky AK, Srinouanprachanh SL, Farin FM, Rettie AE. Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy. JAMA 2002; 287: 1690-8.
7. Flaker GC, Pogue J, Yusuf S, Pfeffer MA, Goldhaber SZ, Granger CB, Anand IS, Hart R, Connolly SJ. Cognitive function and anticoagulation control in patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes 2010; 3: 277-83.
8. Rose AJ, Ozonoff A, Berlowitz DR, Ash AS, Reisman JI, Hylek EM. Reexamining the recommended follow-up interval after obtaining an in-range international normalized ratio value: results from the Veterans Affairs study to improve anticoagulation. Chest 2011; 140: 359-65.
9. Rose AJ, Hylek EM, Ozonoff A, Ash AS, Reisman JI, Berlowitz DR. Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA). J Thromb Haemost 2010; 8: 2182-91.
10. Kimmel SE, Chen Z, Price M, Parker CS, Metlay JP, Christie JD, Brensinger CM, Newcomb CW, Samaha FF, Gross R. The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study. Arch Intern Med 2007; 167: 229.
11. Platt AB, Localio AR, Brensinger CM, Cruess DG, Christie JD, Gross R, Parker CS, Price M, Metlay JP, Cohen A, Newcomb CW, Strom BL, Laskin MS, Kimmel SE. Can we predict daily adherence to warfarin?: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study. Chest 2010; 137: 883-9.
12. Maki ED, Miesner AR, Grady SE, Marschall LM. Effects of depressive and other psychiatric disorders on anticoagulation control in a pharmacist-managed anticoagulation clinic. Ann Pharmacother 2013; 47: 1292-300.
13. Rose AJ, Miller DR, Ozonoff A, Berlowitz DR, Ash AS, Zhao S, Reisman JI, Hylek EM. Gaps in monitoring during oral anticoagulation: insights into care transitions, monitoring barriers, and medication nonadherence. Chest 2013; 143: 751-7.
14. Paradise HT, Berlowitz DR, Ozonoff A, Miller DR, Hylek EM, Ash AS, Jasuja GK, Zhao S, Reisman JI, Rose AJ. Outcomes of anticoagulation therapy in patients with mental health conditions. J Gen Intern Med 2014; 29: 855-61.
15. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007; 370: 851-8.
16. Lyness JM, Kim J, Tang W, Tu X, Conwell Y, King DA, Caine ED. The clinical significance of subsyndromal depression in older primary care patients. Am J Geriatr Psychiatry 2007; 15: 214-23.
17. Lee MJ, Hasche LK, Choi S, Proctor EK, Morrow-Howell N. Comparison of major depressive disorder and subthreshold depression among older adults in community long-term care. Aging Ment Health 2013; 17: 461-9.
18. Schmitz N, Gariepy G, Smith KJ, Clyde M, Malla A, Boyer R, Strychar I, Lesage A, Wang J. Recurrent subthreshold depression in type 2 diabetes: an important risk factor for poor health outcomes. Diabetes Care 2014; 37: 970-8.
19. Katon WJ, Lin EH, von Korff M, Ciechanowski P, Ludman EJ, Young B, Peterson D, Rutter CM, McGregor M, McCulloch D. Collaborative care for patients with depression and chronic illnesses. N Engl J Med 2010; 363: 2611-20.
20. Pan A, Sun Q, Okereke OI, Rexrode KM, Hu FB. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA 2011; 306: 1241-9.
21. Pedersen SS, Denollet J, de Jonge P, Simsek C, Serruys PW, van Domburg RT. Brief depression screening with the PHQ-2 associated with prognosis following percutaneous coronary intervention with paclitaxel-eluting stenting. J Gen Intern Med 2009; 24: 1037-42.
22. Rollman BL, Herbeck Belnap B, Mazumdar S, Houck PR, He F, Alvarez RJ, Schulberg HC, Reynolds CF 3rd, McNamara DM. A positive 2-item Patient Health Questionnaire depression screen among hospitalized heart failure patients is associated with elevated 12-month mortality. J Card Fail 2012; 18: 238-45.
23. Cuijpers P, Vogelzangs N, Twisk J, Kleiboer A, Li J, Penninx BW. Differential mortality rates in major and subthreshold depression: meta-analysis of studies that measured both. Br J Psychiatry 2013; 202: 22-7.
24. Odum LE, Cochran KA, Aistrope DS, Snella KA. The CHADS(2)versus the new CHA2DS2-VASc scoring systems for guiding antithrombotic treatment of patients with atrial fibrillation: review of the literature and recommendations for use. Pharmacotherapy 2012; 32: 285-96.
25. Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care 2003; 41: 1284-92.
26. Thombs BD, Ziegelstein RC, Whooley MA. Optimizing detection of major depression among patients with coronary artery disease using the patient health questionnaire: data from the heart and soul study. J Gen Intern Med 2008; 23: 2014-7.
27. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
28. Caro MA, Sowden GL, Mastromauro CA, Mahnks S, Beach SR, Januzzi JL, Huffman JC. Risk factors for positive depression screens in hospitalized cardiac patients. J Cardiol 2012; 60: 72-7.
29. Arroll B, Goodyear-Smith F, Crengle S, Gunn J, Kerse N, Fishman T, Falloon K, Hatcher S. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med 2010; 8: 348-53.
30. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101-7.
31. Gehi AK, Ali S, Na B, Whooley MA. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med 2007; 167: 1798-803.
32. Gehi A, Haas D, Pipkin S, Whooley MA. Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med 2005; 165: 2508-13.
33. Katon WJ. Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci 2011; 13: 7-23.
34. Guha P, Ghosal M, Chowdhury SP, Chakravarty D. The effect of psychiatric comorbidity on hypertensive patients' perception of medication side-effects. J Indian Med Assoc 2010; 108: 576-8, 80, 82.
35. Ikoma A, Steinhoff M, Stander S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat Rev Neurosci 2006; 7: 535-47.
36. Garner JB. Problems of nonadherence in cardiology and proposals to improve outcomes. Am J Cardiol 2010; 105: 1495-501.
37. Lichtman JH, Bigger JT Jr, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lesperance F, Mark DB, Sheps DS, Taylor CB, Froelicher ES. AHA science advisory. Depression and coronary heart disease. Recommendations for screening, referral, and treatment. A science advisory from the American Heart Association Prevention Committee to the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care Outcomes Research. Endorsed by the American Psychiatric Association. Prog Cardiovasc Nurs 2009; 24: 19-26.
38. Sowden G, Mastromauro CA, Januzzi JL, Fricchione GL, Huffman JC. Detection of depression in cardiac inpatients: feasibility and results of systematic screening. Am Heart J 2010; 159: 780-7.
39. Celano CM, Suarez L, Mastromauro C, Januzzi JL, Huffman JC. Feasibility and utility of screening for depression and anxiety disorders in patients with cardiovascular disease. Circ Cardiovasc Qual Outcomes 2013; 6: 498-504.
40. Michal M, Wiltink J, Till Y, Wild PS, Muenzel T, Blankenberg S, Beutel ME. Type-D personality and depersonalization are associated with suicidal ideation in the German general population aged 35-74: results from the Gutenberg Heart Study. J Affect Disord 2010; 125: 227-33.
41. Corson K, Gerrity MS, Dobscha SK. Screening for depression and suicidality in a VA primary care setting: 2 items are better than 1 item. Am J Manag Care 2004; 10: 839-45.
42. Thombs BD, Roseman M, Coyne JC, de Jonge P, Delisle VC, Arthurs E, Levis B, Ziegelstein RC. Does evidence support the American Heart Association's recommendation to screen patients for depression in cardiovascular care? An updated systematic review. PLoS ONE 2013; 8: e52654.
43. Bauer LK, Caro MA, Beach SR, Mastromauro CA, Lenihan E, Januzzi JL, Huffman JC. Effects of depression and anxiety improvement on adherence to medication and health behaviors in recently hospitalized cardiac patients. Am J Cardiol 2012; 109: 1266-71.
44. Huffman JC, Mastromauro CA, Sowden G, Fricchione GL, Healy BC, Januzzi JL. Impact of a depression care management program for hospitalized cardiac patients. Circ Cardiovasc Qual Outcomes 2011; 4: 198-205.
45. Katon W. Collaborative depression care models: from development to dissemination. Am J Prev Med 2012; 42: 550-2.